ARDELYX, INC. Expense Related to Distribution or Servicing and Underwriting Fees
ARDELYX, INC. (ARDX) reported Expense Related to Distribution or Servicing and Underwriting Fees of $7.80 million for the 0-month period ending 2014-06-18, per its 10-K filed 2015-03-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees · last filed 2016-03-04
- 2014-06-18: Expense Related to Distribution or Servicing and Underwriting Fees 0 month $7.80M; Expense Related to Distribution or Servicing and Underwriting Fees $7.80M.
| Period end | Expense Related to Distribution or Servicing and Underwriting Fees 0 month | Expense Related to Distribution or Servicing and Underwriting Fees |
|---|---|---|
| 2014-06-18 | $7.80M 10-K · filed 2015-03-05 | $7.80M 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |